Hao-Wei Chu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Hao-Wei Chu has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
- Chih-Ching Wu
Graduate Institute of Biomedical Sciences, College of Medicine, Chang Gung University, Taoyuan, Taiwan
4 shared publications - Hao-Ping Liu
Department of Veterinary Medicine, College of Veterinary Medicine, National Chung Hsing University
3 shared publications - Chia-Wei Hsu
Agricultural Biotechnology Research Center, Academia Sinica, Taipei 11529, Taiwan
2 shared publications - Bidyadhar Sethy
Graduate Institute of Natural Products, College of Medicine, Chang Gung University, Taoyuan 33302, Taiwan
1 shared publication Chao-Chin Liu
Department of Medical Biotechnology and Laboratory Science; College of Medicine; Chang Gung University; Tao-Yuan Taiwan
1 shared publicationChi-Chun Li
Department of Medical Biotechnology and Laboratory Science; College of Medicine; Chang Gung University; Tao-Yuan Taiwan
1 shared publication
Latest Publications
- Open Access
Identification of Potential Drug Targets of Broad-Spectrum Inhibitors with a Michael Acceptor Moiety Using Shotgun Proteomics
The Michael addition reaction is a spontaneous and quick chemical reaction that is widely applied in various fields. This reaction is performed by conjugating an addition of nucleophiles with α, β-unsaturated carbonyl compounds, resulting in the bond formation of C-N, C-S, C-O, and so on. In the development of molecular materials, the Michael addition is not only used to synthesize chemical compounds but is also involved in the mechanism of drug action. Several covalent drugs that bond via Michael addition are regarded as anticarcinogens and anti-inflammatory drugs. Although drug development is mainly focused on pharmaceutical drug discovery, target-based discovery can provide a different perspective for drug usage. However, considerable time and labor are required to define a molecular target through molecular biological experiments. In this review, we systematically examine the chemical structures of current FDA-approved antiviral drugs for potential Michael addition moieties with α, β-unsaturated carbonyl groups, which may exert an unidentified broad-spectrum inhibitory mechanism to target viral or host factors. We thus propose that profiling the targets of antiviral agents, such as Michael addition products, can be achieved by employing a high-throughput LC-MS approach to comprehensively analyze the interaction between drugs and targets, and the subsequent drug responses in the cellular environment to facilitate drug repurposing and/or identify potential adverse effects, with a particular emphasis on the pros and cons of this shotgun proteomic approach.
Open AccessIdentification of Potential Drug Targets of Broad-Spectrum Inhibitors with a Michael Acceptor Moiety Using Shotgun Proteomics
The Michael addition reaction is a spontaneous and quick chemical reaction that is widely applied in various fields. This reaction is performed by conjugating an addition of nucleophiles with α, β-unsaturated carbonyl compounds, resulting in the bond formation of C-N, C-S, C-O, and so on. In the development of molecular materials, the Michael addition is not only used to synthesize chemical compounds but is also involved in the mechanism of drug action. Several covalent drugs that bond via Michael addition are regarded as anticarcinogens and anti-inflammatory drugs. Although drug development is mainly focused on pharmaceutical drug discovery, target-based discovery can provide a different perspective for drug usage. However, considerable time and labor are required to define a molecular target through molecular biological experiments. In this review, we systematically examine the chemical structures of current FDA-approved antiviral drugs for potential Michael addition moieties with α, β-unsaturated carbonyl groups, which may exert an unidentified broad-spectrum inhibitory mechanism to target viral or host factors. We thus propose that profiling the targets of antiviral agents, such as Michael addition products, can be achieved by employing a high-throughput LC-MS approach to comprehensively analyze the interaction between drugs and targets, and the subsequent drug responses in the cellular environment to facilitate drug repurposing and/or identify potential adverse effects, with a particular emphasis on the pros and cons of this shotgun proteomic approach.
- Open Access
- 1 September 2019
- Published by Elsevier in Molecular & Cellular Proteomics
- Vol. 18 (9) , 1796-1806
Identification of Salivary Biomarkers for Oral Cancer Detection with Untargeted and Targeted Quantitative Proteomics Approaches
- 1 September 2019
- Published by Elsevier in Molecular & Cellular Proteomics
- Vol. 18 (9) , 1796-1806
Open AccessIdentification of Salivary Biomarkers for Oral Cancer Detection with Untargeted and Targeted Quantitative Proteomics Approaches
- 22 December 2018
- Published by Wiley in Proteomics – Clinical Applications
- Vol. 13 (4) , e1800151
Proteome Analyses Reveal Positive Association of COL2A1, MPO, TYMS, and IGFBP5 with Canine Mammary Gland Malignancy
Purpose : To identify aberrantly expressed proteins contributing to pathogenesis of canine mammary tumors (CMT) which are the most prevalent neoplasms in female dogs and include different types. Experimental design : Frozen tissue specimens of normal mammary gland (n = 7), lobular hyperplasia (n = 6), simple carcinoma (n = 6) and complex carcinoma (n = 6) were collected from 11 CMT cases. Tissue homogenates were comparatively analyzed by iTRAQ combined with LC‐MS/MS to identify proteins differentially expressed in different‐type CMT tissues. Results : Among 3,795 proteins identified and quantified among all groups, 133, 127 and 98 proteins were particularly overexpressed in simple carcinoma, complex carcinoma, and both types, respectively, compared with normal and hyperplastic tissues. Functional annotation revealed that proteins overexpressed in simple carcinoma and complex carcinoma are primarily involved in mRNA regulation and cell adhesion/collagen organization, respectively. Moreover, COL2A1, MPO, TYMS, and IGFBP5 proteins were validated to be highly expressed in different‐type CMT tissues using immunoblotting and immunohistochemistry. Notably, COL2A1 and IGFBP5 levels were correlated with clinical stages. Conclusions and clinical relevance : COL2A1, MPO, TYMS and IGFBP5 protein levels are positively associated with CMT development. Data prompt further investigations to improve treatment regimens for CMT.
- 22 December 2018
- Published by Wiley in Proteomics – Clinical Applications
- Vol. 13 (4) , e1800151
Proteome Analyses Reveal Positive Association of COL2A1, MPO, TYMS, and IGFBP5 with Canine Mammary Gland Malignancy
Purpose : To identify aberrantly expressed proteins contributing to pathogenesis of canine mammary tumors (CMT) which are the most prevalent neoplasms in female dogs and include different types. Experimental design : Frozen tissue specimens of normal mammary gland (n = 7), lobular hyperplasia (n = 6), simple carcinoma (n = 6) and complex carcinoma (n = 6) were collected from 11 CMT cases. Tissue homogenates were comparatively analyzed by iTRAQ combined with LC‐MS/MS to identify proteins differentially expressed in different‐type CMT tissues. Results : Among 3,795 proteins identified and quantified among all groups, 133, 127 and 98 proteins were particularly overexpressed in simple carcinoma, complex carcinoma, and both types, respectively, compared with normal and hyperplastic tissues. Functional annotation revealed that proteins overexpressed in simple carcinoma and complex carcinoma are primarily involved in mRNA regulation and cell adhesion/collagen organization, respectively. Moreover, COL2A1, MPO, TYMS, and IGFBP5 proteins were validated to be highly expressed in different‐type CMT tissues using immunoblotting and immunohistochemistry. Notably, COL2A1 and IGFBP5 levels were correlated with clinical stages. Conclusions and clinical relevance : COL2A1, MPO, TYMS and IGFBP5 protein levels are positively associated with CMT development. Data prompt further investigations to improve treatment regimens for CMT.
- 23 February 2018
- Published by Wiley in Proteomics
- Vol. 18 (5-6) , e1700195
Exoproteome Profiling Reveals the Involvement of the Foldase PrsA in the Cell Surface Properties and Pathogenesis ofStaphylococcus aureus
Staphylococcus aureus is a bacterial pathogen that produces and exports many virulence factors that cause diseases in human. PrsA, a membrane-bound foldase, is expressed ubiquitously in Gram-positive bacteria and required for the folding of exported proteins into a stable and active structure. To understand the involvement of PrsA in post-translocational protein folding in S. aureus, a PrsA-deficient mutant of S. aureus HG001 was constructed. Using isobaric tags for relative and absolute quantification (iTRAQ)-based mass spectrometry analyses, the exoproteomes of PrsA mutant and wild type S. aureus were comparatively profiled, and 163 cell wall-associated proteins and 67 exoproteins with altered levels have been identified in the PrsA-deficient mutant. Bioinformatics analyses further reveal that prsA deletion altered the amounts of proteins that are potentially involved in the regulation of cell surface properties and bacterial pathogenesis. To determine the relevancy of our findings, we investigated the functional consequence of prsA deletion in S. aureus. PrsA deficiency can enhance bacterial auto-aggregation and increase the adhesion ability of S. aureus to human lung epithelial cells. Moreover, mice infected with PrsA-deficient S. aureus had a better survival rate compared with those infected with the wild-type S. aureus. Collectively, our findings reveal that PrsA is required for the post-translocational folding of numerous exported proteins and critically affects the cell surface properties and pathogenesis of S. aureus.
- 23 February 2018
- Published by Wiley in Proteomics
- Vol. 18 (5-6) , e1700195
Exoproteome Profiling Reveals the Involvement of the Foldase PrsA in the Cell Surface Properties and Pathogenesis ofStaphylococcus aureus
Staphylococcus aureus is a bacterial pathogen that produces and exports many virulence factors that cause diseases in human. PrsA, a membrane-bound foldase, is expressed ubiquitously in Gram-positive bacteria and required for the folding of exported proteins into a stable and active structure. To understand the involvement of PrsA in post-translocational protein folding in S. aureus, a PrsA-deficient mutant of S. aureus HG001 was constructed. Using isobaric tags for relative and absolute quantification (iTRAQ)-based mass spectrometry analyses, the exoproteomes of PrsA mutant and wild type S. aureus were comparatively profiled, and 163 cell wall-associated proteins and 67 exoproteins with altered levels have been identified in the PrsA-deficient mutant. Bioinformatics analyses further reveal that prsA deletion altered the amounts of proteins that are potentially involved in the regulation of cell surface properties and bacterial pathogenesis. To determine the relevancy of our findings, we investigated the functional consequence of prsA deletion in S. aureus. PrsA deficiency can enhance bacterial auto-aggregation and increase the adhesion ability of S. aureus to human lung epithelial cells. Moreover, mice infected with PrsA-deficient S. aureus had a better survival rate compared with those infected with the wild-type S. aureus. Collectively, our findings reveal that PrsA is required for the post-translocational folding of numerous exported proteins and critically affects the cell surface properties and pathogenesis of S. aureus.
- 22 July 2015
- Published by Wiley in Proteomics
- Vol. 15 (19) , 3394-3404
Saliva proteome profiling reveals potential salivary biomarkers for detection of oral cavity squamous cell carcinoma
Oral cavity squamous cell carcinoma (OSCC), which is frequently associated with poor prognosis and mortality, is a leading cause of cancer‐related death worldwide. Discovery of body fluid accessible biomarkers is needed to improve OSCC screening. To this end, we profiled proteomes of saliva from the healthy volunteers, the individuals with oral potentially malignant disorders (OPMD), and the OSCC patients by means of SDS‐PAGE coupled with LC‐MS/MS. In the control, the OPMD, and the OSCC groups, 958, 845, and 1030 salivary proteins were detected, respectively. With spectral counting‐based label‐free quantification, 22 overexpressed salivary proteins were identified in the OSCC group compared with the healthy controls and the OPMD individuals. Among them, resistin (RETN) was subjected to further validation with an independent cohort using ELISA. The data confirmed that the salivary RETN levels in the OSCC patients were significantly higher than that in the healthy or in the OPMD group. Moreover, the elevated levels of salivary RETN were highly correlated with late‐stage primary tumors, advanced overall stage, and lymph‐node metastasis. Our results not only reveal that profiling of saliva proteome is feasible for discovery of OSCC biomarkers, but also identify RETN as a potential salivary biomarker for OSCC detection.
- 22 July 2015
- Published by Wiley in Proteomics
- Vol. 15 (19) , 3394-3404
Saliva proteome profiling reveals potential salivary biomarkers for detection of oral cavity squamous cell carcinoma
Oral cavity squamous cell carcinoma (OSCC), which is frequently associated with poor prognosis and mortality, is a leading cause of cancer‐related death worldwide. Discovery of body fluid accessible biomarkers is needed to improve OSCC screening. To this end, we profiled proteomes of saliva from the healthy volunteers, the individuals with oral potentially malignant disorders (OPMD), and the OSCC patients by means of SDS‐PAGE coupled with LC‐MS/MS. In the control, the OPMD, and the OSCC groups, 958, 845, and 1030 salivary proteins were detected, respectively. With spectral counting‐based label‐free quantification, 22 overexpressed salivary proteins were identified in the OSCC group compared with the healthy controls and the OPMD individuals. Among them, resistin (RETN) was subjected to further validation with an independent cohort using ELISA. The data confirmed that the salivary RETN levels in the OSCC patients were significantly higher than that in the healthy or in the OPMD group. Moreover, the elevated levels of salivary RETN were highly correlated with late‐stage primary tumors, advanced overall stage, and lymph‐node metastasis. Our results not only reveal that profiling of saliva proteome is feasible for discovery of OSCC biomarkers, but also identify RETN as a potential salivary biomarker for OSCC detection.